Two Faces of Catechol-O-Methyltransferase Inhibitor on One-Carbon Metabolism in Parkinson’s Disease: A Meta-Analysis

Levodopa (L-dopa) and catechol-O-methyltransferase (COMT) inhibition are widely used therapeutics in Parkinson’s disease (PD). Despite their therapeutic effects, it was raised that nutrients involved in one-carbon metabolism can be deteriorated by PD therapies. The aim of this meta-analysis was to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin Hee, Jin, Shaoyue, Eo, Hyeyoon, Oh, Myung Sook, Lim, Yunsook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964466/
https://www.ncbi.nlm.nih.gov/pubmed/36839259
http://dx.doi.org/10.3390/nu15040901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964466/
https://www.ncbi.nlm.nih.gov/pubmed/36839259
http://dx.doi.org/10.3390/nu15040901

Ejemplares similares